Robert Hopp, MD
Dermatology · Kennewick, WANPI 1801835509
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Novartis at 50.5% of the total. Reporting peaked in 2022 at $164 and has fallen 91.2% since, to $14 in 2025. That places this record below the midpoint for dermatology clinicians in WA, where the typical reported total is $698.
Across 28 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$277
- Arcutis Biotherapeutics, Inc.$66
- E.r. Squibb & Sons, L.L.C.$57
- Amgen$28
- LEO Pharma Inc.$26
- Sanofi-aventis U.S. LLC$21
- plus $74 from 5 others
Across 11 payments — averaging $2506.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$27K
- Janssen Research & Development, LLC$512
What the payments were for
- Food & beverage$548100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 14 | $277 |
| Arcutis Biotherapeutics, Inc. | 3 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Amgen | 1 | $28 |
| LEO Pharma Inc. | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Sanofi | 1 | $19 |
| Genentech USA, Inc. | 1 | $15 |
| Strata Skin Sciences, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $12 |
How this compares
$548 in reported general payments places this provider in the 45th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 15 | $499 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Kennewick
- Melissa JaegerKennewick$6K
- Clive LiuBellevue$2.9M
- Vivian ShiSeattle$971K
- William WerschlerSpokane$948K
- Daniel LevyBonney Lake$541K
- Daniel SugaiBellevue$302K
- Ting-Lin YangBellingham$124K
- James CollyerSeattle$115K
- Cameron ChesnutSpokane$93K
- Alison YoungSeattle$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.